The Office for Attracting Strategic Enterprises has successfully engaged over 200 companies in the past eight months, resulting in 25 firms, including several biotechs, establishing or planning offices in Hong Kong, according to director-general Philip Yung Wai-hung. Speaking at the annual biotech summit by Hong Kong Exchanges and Clearing (HKEX), HKEX CEO Nicolas Aguzin highlighted the influx of listing applications from overseas biotech entities. He also mentioned the imminent opening of HKEX’s London office to foster global connectivity. HKEX recently showcased Aguzin’s fondness for Hong Kong’s red taxis in a video, emphasising the city’s global market reach. Furthermore, 60 biotech firms have been publicly listed in the city under the Chapter 18A rule, raising a collective HKD119bn as of August.
top of page
bottom of page